DF
Douglas Forsyth
Director

Douglas Forsyth insider trades: Inhibrx Biosciences (INBX) stock buys and sales

Director, Inhibrx Biosciences Last trade Sep 8, 2026 17 Form 4 filings
$0
Sold, last 12 months
0 sales
$287K
Bought, last 12 months
1 buy
9
Open-market trades
since 2007
4
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Douglas reports to the SEC

Open-market buys and sales

9 trades reported on SEC Form 4, newest first

DateStockTypeValue
Sep 8, 2026INBX↑ Buy$287K
Aug 23, 2024INBX↑ Buy$1.0M
Aug 11, 2020NIE↓ Sell$493K
Jun 25, 2014NCV↓ Sell$159K
Sep 18, 2008NIE↑ Buy$119K
Sep 18, 2008NIE↑ Buy$32K
Aug 17, 2007NIE↑ Buy$108K
Aug 16, 2007NIE↑ Buy$98K
Aug 15, 2007NCV↑ Buy$177K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other INBX insiders

Open-market trades in the last 12 months

About Douglas Forsyth's insider trades

Douglas Forsyth is a director at Inhibrx Biosciences (INBX). Since Aug 15, 2007, Douglas has reported 7 open-market purchases worth $1.9M and 2 sales worth $652K on SEC Form 4. In the last 12 months: 1 buy ($287K).

Their filings also include grants and awards (7 filings), shares returned to the company (1 filing), conversions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every INBX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.